| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:52 UTC |
|---|
| Update Date | 2022-03-07 02:52:01 UTC |
|---|
| HMDB ID | HMDB0015546 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Propericiazine |
|---|
| Description | Propericiazine, also known as piperocyanomazine or neuleptil, belongs to the class of organic compounds known as phenothiazines. These are polycyclic aromatic compounds containing a phenothiazine moiety, which is a linear tricyclic system that consists of a two benzene rings joined by a para-thiazine ring. Propericiazine is a drug which is used for use as adjunctive medication in some psychotic patients. propericiazine (pericyazine)is used for the control of residual prevailing hostility, impulsiveness and aggressiveness. . The primary uses of periciazine include in the short-term treatment of severe anxiety or tension and in the maintenance treatment of psychotic disorders such as schizophrenia. Propericiazine is a very strong basic compound (based on its pKa). Periciazine is a rather sedating and anticholinergic antipsychotic, and despite being classed with the typical antipsychotics, its risk of extrapyramidal side effects is comparatively low. It is commonly sold in Canada and Russia under the tradename Neuleptil and in United Kingdom and Australia under the tradename Neulactil. Periciazine is not approved for sale in the United States. It has a relatively high risk of causing hyperprolactinaemia and a moderate risk of causing weight gain and orthostatic hypotension. There is insufficient evidence to determine whether periciazine is more or less effective than other antipsychotics. A 2014 systematic review compared periciazine with typical antipsychotics for schizophrenia:Periciazine has also been studied in the treatment of opioid dependence. |
|---|
| Structure | OC1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C#N)CC1 InChI=1S/C21H23N3OS/c22-15-16-6-7-21-19(14-16)24(18-4-1-2-5-20(18)26-21)11-3-10-23-12-8-17(25)9-13-23/h1-2,4-7,14,17,25H,3,8-13H2 |
|---|
| Synonyms | | Value | Source |
|---|
| 10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile | ChEBI | | 2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine | ChEBI | | 2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine | ChEBI | | Cyano-3 ((hydroxy-4 piperidyl-1)-3 propyl)-10 phenothiazine | ChEBI | | Periciazina | ChEBI | | Periciazinum | ChEBI | | Piperocyanomazine | ChEBI | | Periciazine | Kegg | | Neuleptil | Kegg | | Pericyazine | HMDB | | Aolept | HMDB | | Neuleptyl | HMDB | | Propericiazine | ChEBI |
|
|---|
| Chemical Formula | C21H23N3OS |
|---|
| Average Molecular Weight | 365.492 |
|---|
| Monoisotopic Molecular Weight | 365.156183063 |
|---|
| IUPAC Name | 10-[3-(4-hydroxypiperidin-1-yl)propyl]-10H-phenothiazine-2-carbonitrile |
|---|
| Traditional Name | propericiazine |
|---|
| CAS Registry Number | 2622-26-6 |
|---|
| SMILES | OC1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C#N)CC1 |
|---|
| InChI Identifier | InChI=1S/C21H23N3OS/c22-15-16-6-7-21-19(14-16)24(18-4-1-2-5-20(18)26-21)11-3-10-23-12-8-17(25)9-13-23/h1-2,4-7,14,17,25H,3,8-13H2 |
|---|
| InChI Key | LUALIOATIOESLM-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenothiazines. These are polycyclic aromatic compounds containing a phenothiazine moiety, which is a linear tricyclic system that consists of a two benzene rings joined by a para-thiazine ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzothiazines |
|---|
| Sub Class | Phenothiazines |
|---|
| Direct Parent | Phenothiazines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenothiazine
- Alkyldiarylamine
- Diarylthioether
- Aryl thioether
- Tertiary aliphatic/aromatic amine
- Para-thiazine
- Piperidine
- Benzenoid
- Secondary alcohol
- Tertiary aliphatic amine
- Tertiary amine
- Carbonitrile
- Nitrile
- Azacycle
- Thioether
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Alcohol
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Amine
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 116 - 117 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.059 g/L | Not Available | | LogP | 3.52 | HANSCH,C ET AL. (1995) |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.58 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.6505 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.24 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 105.0 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1005.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 208.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 171.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 187.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 102.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 332.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 391.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 682.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 814.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 287.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 984.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 220.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 334.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 617.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 489.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 80.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - Propericiazine EI-B (Non-derivatized) | splash10-03xu-7932000000-163720fa7ee8e5adf313 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Propericiazine EI-B (Non-derivatized) | splash10-03di-4931000000-bc6eaf361b17af48a30f | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Propericiazine EI-B (Non-derivatized) | splash10-03xu-7932000000-163720fa7ee8e5adf313 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Propericiazine EI-B (Non-derivatized) | splash10-03di-4931000000-bc6eaf361b17af48a30f | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Propericiazine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0btl-9443000000-0bf7e572c89eab0eebe0 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Propericiazine GC-MS (1 TMS) - 70eV, Positive | splash10-00g0-9532200000-0fac63dfe3ca1b1e5d68 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Propericiazine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Propericiazine 10V, Positive-QTOF | splash10-00kb-0009000000-ea2a928d0b477b642d28 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Propericiazine 20V, Positive-QTOF | splash10-00kb-1319000000-d734a3c87a7e3896e919 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Propericiazine 40V, Positive-QTOF | splash10-05x0-4941000000-090633fd54a2d8de3a65 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Propericiazine 10V, Negative-QTOF | splash10-03di-0009000000-2c21e3a159ee7e81d892 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Propericiazine 20V, Negative-QTOF | splash10-0nvj-0094000000-6287516a8e31f1411d1f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Propericiazine 40V, Negative-QTOF | splash10-00di-4690000000-8c2afe6a37eb44b04235 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Propericiazine 10V, Positive-QTOF | splash10-014i-0009000000-3bd5b70543953e9fd1fa | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Propericiazine 20V, Positive-QTOF | splash10-00xu-0907000000-bed0c5fa41577c9ffdc3 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Propericiazine 40V, Positive-QTOF | splash10-00di-7794000000-f64312cc0eaedb856528 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Propericiazine 10V, Negative-QTOF | splash10-03di-0009000000-b9605fed856fbbd87811 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Propericiazine 20V, Negative-QTOF | splash10-03di-0059000000-7912c18269b0b9534e79 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Propericiazine 40V, Negative-QTOF | splash10-00di-0292000000-ff380871c3b00965659f | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|